Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations

被引:39
|
作者
Leone, Federica [1 ,2 ]
Cavalli, Roberta [3 ]
机构
[1] Univ Turin, Dept Drug Sci & Technol, I-10125 Turin, Italy
[2] Politecn Torino, Mat Sci & Technol, Dept Appl Sci & Technol, I-10129 Turin, Italy
[3] Univ Turin, Dept Drug Sci & Technol, Pharmaceut Technol, Via Pietro Giuria 9, I-10125 Turin, Italy
关键词
bioavailability; drug delivery; nanomedicine; nanosuspensions; pure drug nanocrystals; solubility enhancement; PARTICLE-SIZE REDUCTION; POORLY SOLUBLE DRUGS; IN-VITRO; NANOCRYSTAL FORMULATION; TISSUE DISTRIBUTION; DELIVERY; PHARMACOKINETICS; NANOPARTICLES; DISSOLUTION; CLASSIFICATION;
D O I
10.1517/17425247.2015.1043886
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: A nanosuspension or nanocrystal suspension is a versatile formulation combining conventional and innovative features. It comprises 100% pure drug nanoparticles with sizes in the nano-scale range, generally stabilized by surfactants or polymers. Nanosuspensions are usually obtained in liquid media with bottom-up and top-down methods or by their combination. They have been designed to enhance the solubility, the dissolution rate and the bioavailability of drugs via various administration routes. Due to their small sizes, nanosuspensions can be also considered a drug delivery nanotechnology for the preparation of nanomedicine products.Areas covered: This review focuses on the state of the art of the nanocrystal-based formulation. It describes theory characteristics, design parameters, preparation methods, stability issues, as well as specific in vivo applications. Innovative strategies proposed to obtain nanomedicine formulation using nanocrystals are also reported.Expert opinion: Many drug nanodelivery systems have been developed to increase the bioavailability of drugs and to decrease adverse side effects, but few can be industrially manufactured. Nanocrystals can close this gap by combining traditional and innovative drug formulations. Indeed, they can be used in many pharmaceutical dosage forms as such, or developed as new nano-scaled products. Engineered surface nanocrystals have recently been proposed as a dual strategy for stability enhancement and targeting delivery of nanocrystals.
引用
收藏
页码:1607 / 1625
页数:19
相关论文
共 50 条
  • [1] Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches
    Karve, Tanvi
    Dandekar, Amruta
    Agrahari, Vivek
    Peet, M. Melissa
    Banga, Ajay K.
    Doncel, Gustavo F.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2024, 210
  • [2] An Innovative Concept in Pharmaceutical Drug Development
    Rolf F. Tiggemann
    Hermann Sabel
    [J]. Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 119 - 124
  • [3] Nanocrystals and nanosuspensions: an exploration from classic formulations to advanced drug delivery systems
    Rossier, Benjamin
    Jordan, Olivier
    Allemann, Eric
    Rodriguez-Nogales, Carlos
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2024,
  • [4] Physiological and Pharmaceutical Considerations for Rectal Drug Formulations
    Hua, Susan
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] NEW CLASSIFICATION OF TRADITIONAL AND INNOVATIVE PHARMACEUTICAL PAYMENT METHODS
    Hermanowski, T.
    Czech, M.
    Chmielewska, M.
    Kiljan, A.
    Drozdowska, A.
    Zawodnik, S.
    Pashos, C. L.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A295 - A295
  • [6] Innovative formulations of the orphan drug sodium benzoate
    Krause, J
    Breitkreutz, J
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 : S18 - S18
  • [7] Production of Nanosuspensions as a Tool to Improve Drug Bioavailability: Focus on Topical Delivery
    Lai, Francesco
    Schlich, Michele
    Pireddu, Rosa
    Corrias, Francesco
    Fadda, Anna Maria
    Sinico, Chiara
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (42) : 6089 - 6103
  • [8] The innovative pharmaceutical company and drug development - Comment
    Drews, J
    Ryser, S
    [J]. CHEMTECH, 1998, 28 (12) : 7 - 9
  • [9] Macrocycles as drug-enhancing excipients in pharmaceutical formulations
    Gu, Alice
    Wheate, Nial J.
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2021, 100 (1-2) : 55 - 69
  • [10] Pharmaceutical challenges and perspectives in developing ophthalmic drug formulations
    Maharjan P.
    Cho K.H.
    Maharjan A.
    Shin M.C.
    Moon C.
    Min K.A.
    [J]. Journal of Pharmaceutical Investigation, 2019, 49 (2) : 215 - 228